Mark Page
Geen lopende functies
Profiel
Mark Page worked as a Senior Director of Marketing at Arstasis, Inc. from 2010 to 2014, as well as a Vice President of Marketing at FlowCardia, Inc. from 2005 to 2010.
He also held Marketing Manager positions at Target Therapeutics, Inc. and Boston Scientific Corp.
Additionally, he served as the Vice President of Strategic Initiatives at Silk Road Medical, Inc. from 2014 to 2022.
Mr. Page received his undergraduate degree from Fairfield University.
Eerdere bekende functies van Mark Page
Bedrijven | Functie | Einde |
---|---|---|
SILK ROAD MEDICAL, INC | Corporate Officer/Principal | 01-08-2022 |
Arstasis, Inc.
Arstasis, Inc. Electronic Equipment/InstrumentsElectronic Technology Arstasis, Inc. develops and manufactures medical devices for femoral catheterizations. It offers AXERA access device, a vascular access device that is used in patients undergoing diagnostic femoral artery catheterization procedures using 5F or 6F introducer sheaths. The company was founded in August 2004 by D. Bruce Modesitt and is headquartered in Fremont, CA. | Verkoop & Marketing | 01-06-2014 |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Verkoop & Marketing | 01-07-2010 |
Target Therapeutics, Inc.
Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Verkoop & Marketing | - |
BOSTON SCIENTIFIC CORPORATION | Verkoop & Marketing | - |
Opleiding van Mark Page
Fairfield University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
SILK ROAD MEDICAL, INC | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Health Technology |
Kendall Healthcare Products | |
Target Therapeutics, Inc.
Target Therapeutics, Inc. Medical SpecialtiesHealth Technology Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA. | Health Technology |
Arstasis, Inc.
Arstasis, Inc. Electronic Equipment/InstrumentsElectronic Technology Arstasis, Inc. develops and manufactures medical devices for femoral catheterizations. It offers AXERA access device, a vascular access device that is used in patients undergoing diagnostic femoral artery catheterization procedures using 5F or 6F introducer sheaths. The company was founded in August 2004 by D. Bruce Modesitt and is headquartered in Fremont, CA. | Electronic Technology |